GILD Financial Facts
Total costs and expenses: 3.1BCost of goods sold: 1.13B
See Full Income Statement
Noncurrent portion of prepaid royalties: 439M
Noncurrent deferred tax assets: 481M
See Full Balance Sheet
Gilead Sciences Inc. (GILD) Earnings
|
Expand Research on GILD
| Next EPS Date | 4/25/24 | EPS Growth Rate | +13.9% |
|---|---|---|---|
| Average EPS % Beat Rate | -2.9% | Revenue Growth Rate | -0.6% |
| Average % Move 1-Wk after EPS | -3.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/25/24  |
Q124 | N/A | $1.56 | N/A | N/A | $6.36B | = | N/A | N/A | ||
| 5/2/13 |
 |
Q113 | $0.48 | $0.50 | -$0.02 | $2.53B | $2.58B |  |
 | | Details |
| 2/4/13 |
|
Q412 | $0.50 | $0.48 | +$0.02 | $2.59B | $2.43B | |
| | Details |
| 7/25/13 |
|
Q213 | $0.50 | $0.50 | $0.00 | $2.77B | $2.66B | |
| | Details |
| 10/29/13 |
|
Q313 | $0.52 | $0.48 | +$0.04 | $2.78B | $2.72B | |
| | Details |
| 2/4/14 |
|
Q413 | $0.55 | $0.50 | +$0.05 | $3.04B | $2.85B | = | | | Details |
| 2/1/22 | |
Q421 | $0.69 | $1.52 | -$0.83 | $7.2B | $6.51B | = | | | Details |
| 4/20/11 |
|
Q111 | $0.87 | $0.98 | -$0.11 | $2.09B | $2.04B | N/A | | | Details |
